| Literature DB >> 30556184 |
Enrico Bottero1, Emanuele Mussi2, Camillo Pieramati3, Davide De Lorenzi4, Serenella Silvestri3, Elvio Lepri3.
Abstract
BACKGROUND: In clinical practice, histopathological diagnosis of chronic intestinal disease is challenging because of difficulty in obtaining adequate duodenal samples. At present, no studies have investigated the influence of biopsy forceps size on sample quality in cats.Entities:
Keywords: biopsy forceps; cats; endoscopy; gastrointestinal diseases; inflammatory bowel disease; lymphoma
Mesh:
Year: 2018 PMID: 30556184 PMCID: PMC6430887 DOI: 10.1111/jvim.15356
Source DB: PubMed Journal: J Vet Intern Med ISSN: 0891-6640 Impact factor: 3.333
Figure 1Comparison of the dimensions of the smaller (left, 1.8 mm) and larger (right, 2.4 mm) biopsy forceps
Figure 2(A) Comparison of the gross dimensions of the biopsy performed with the smaller (bottom) and the larger forceps (top). (B‐F) Duodenum, hematoxylin and eosin stain, 4×. Scale bar = 200 μm. (B) Marginal sample. (C, D) Samples marginal because of the orientation: only the superficial lamina propria (C) or only the cryptal mucosa is present (D). (E) Backwardly oriented sample. (F) Roll over artifact
Biopsy adequacy and orientation
| Mean ± SD | CI95% |
| ||
|---|---|---|---|---|
| L | S |
| ||
| Total biopsies (n) | 5.36 ± 1.54 | 5.04 ± 1.62 | −0.17 to 0.81 | .19 |
| Adequacy (%) | ||||
| Evaluable | 82.09 ± 24.13 | 70.03 ± 31.93 | 0.37 to 20.52 |
|
| Adequate | 39.77 ± 27.1 | 21.7 ± 24.08 | 8.53 to 24.65 |
|
| Marginal | 16.02 ± 23.72 | 25.67 ± 26.6 | −18.73 to −1.17 |
|
| Marginal for orientation | 26.63 ± 31.14 | 22.66 ± 26.9 | −6.71 to 12.1 | .57 |
| Inadequate | 17.24 ± 23.92 | 29.24 ± 32.06 | −20.32 to −0.01 |
|
| Orientation (%) | ||||
| Proper | 35.27 ± 31.7 | 42.01 ± 34.84 | −17.94 to 5.12 | .27 |
| Backwards | 22.59 ± 23.18 | 19.73 ± 28.37 | −4.16 to 12.12 | .33 |
| Inadequate | 42.14 ± 36.07 | 38.26 ± 35.63 | −9.92 to 12.93 | .79 |
Abbreviations: CI95%, 95% confidence interval of the difference; L, larger forceps; S, smaller forceps.
Values in bold are statistically significant (P ≤ .05)
Figure 3Boxplots of adequacy and orientation with the larger (L) and smaller (S) forceps. The symbol indicates a significant difference at P ≤ .05 (*), P ≤ .01 (**), or P ≤ .001 (***)
Biopsy artifacts and villi morphology
| Present | Absent | Test | |||
|---|---|---|---|---|---|
| L | S | L | S |
| |
| Artifacts (%) | |||||
| Presence of artifacts | 29/49 (60%) | 31/46 (67%) | 20/49 (40%) | 15/46 (33%) | .41 |
| Artifact quantity (mean) | 8.32% (±11.38) | 8.64% (±11.73) | NA | NA | .85 |
| Compression artifact | 14/49 (29%) | 12/46 (26%) | 35/49 (71%) | 34/46 (74%) | .79 |
| Streaming chromatin | 19/49 (39%) | 23/46 (50%) | 30/49 (61%) | 23/46 (50%) | .27 |
| Roll‐over artifact | 11/49 (22%) | 5/46 (11%) | 38/49 (78%) | 41/46 (89%) | .13 |
| Villi (%) | |||||
| Evaluable villi | 44/50 (88%) | 39/50 (78%) | 6/50 (12%) | 11/50 (22%) | .18 |
| Blunting | 6/44 (14%) | 3/39 (0.08%) | 38/44 (86%) | 36/39 (99.02%) | .38 |
| Fusion | 1/44 (0.02%) | 1/39 (0.03%) | 43/44 (99.08%) | 38/39 (99.07%) | .93 |
| Distortion | 4/44 (0.09%) | 3/39 (0.08%) | 40/44 (99.01%) | 36/39 (99.02%) | .82 |
Abbreviations: L, larger forceps; NA, not applicable; S, smaller forceps.
t‐test for mean difference of quantity of artifact; χ2 test for association of forceps size with artifact types.
Not applicable = 5.
Agreement on histological features
| Forceps | McNemar χ2 test | ||||
|---|---|---|---|---|---|
| L | S | κ‐test | CI95%
|
| |
| Single lesions | |||||
| LP | 39/49 (79.59%) | 35/46 (76.09%) | 0.57 | 0.21 to 0.83 | 1 |
| Eosinophilic infiltration | 15/49 (30.61%) | 13/46 (28.26%) | 0.68 | 0.38 to 0.88 | 1 |
| Neutrophilic infiltration | 16/49 (32.65%) | 9/46 (19.57%) | 0.52 | 0.20 to 0.78 | .29 |
| Atrophy | 0/49 (0%) | 1/46 (2.17%) | NA | NA | NA |
| Fibrosis | 3/49 (6.12%) | 4/46 (8.7%) | −0.08 | −0.14 to 0 | 1 |
| Lymphoma | 9/49 (18.37%) | 8/46 (17.39%) | 0.78 | 0.42 to 1 | 1 |
| Small cell lymphoma | 7/49 (14.29%) | 7/46 (15.22%) | 0.66 | 0.23 to 0.92 | 1 |
| Medium cell lymphoma | 1/49 (2.04%) | 0/46 (0%) | NA | NA | NA |
| Large cell lymphoma | 1/49 (2.04) | 1/46 (2.17%) | 1 | NA | NA |
| Main diagnosis | |||||
| Inflammation/neoplasia versus others | 48/49 (97.96%) | 43/46 (93.48%) | −0.03 | −0.13 to 0 | .62 |
| Neoplastic versus non‐neoplastic | 10/49 (79.59%) | 11/46 (76.09%) | 0.56 | 0.23 to 0.83 | 1 |
| LP versus small cell lymphoma versus others | |||||
| LP | 39/49 (79.59%) | 35/46 (76.09%) | 0.53 | 0.23 to 0.79 | .50 |
| Small cell lymphoma | 7/49 (14.29%) | 7/46 (15.22%) | |||
| Others | 3/49 (6.12%) | 4/46 (8.70%) | |||
Abbreviations: L, larger forceps; NA, not applicable; S, smaller forceps; LP, lymphoplasmacytic infiltration.
95% confidence interval of κ based on bootstrapping (10 000 replicates).